𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinically isolated mandibular relapse in childhood acute leukemia

✍ Scribed by Marjorie Rush; Béla B. Toth; Donald Pinkel

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
369 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to combination therapy after re
Response to combination therapy after relapse in childhood acute lymphocytic leukemia
✍ Rhomes J. A. Aur; M. S. Verzosa; H. Omar Hustu; J. V. Simone 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

The objective of this study was to determine in children with acute lym phocytic leukemia (ALL) whether prolonged remission could be attained following relapse from prior chemotherapy. Multiple agent chemotherapy and central nervous system radiotherapy were administered to 16 children who had had on

Testicular relapse in children with acut
Testicular relapse in children with acute nonlymphoblastic leukemia
✍ Wayne L. Furman; James Fontanesi; Omar Hustu; Gary V. Dahl; David K. Kalwinsky; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 2 views

The clinical course and other distinctive features of five children who developed a testicular relapse 4 months to 25 months after the diagnosis of acute nonlymphoblastic leukemia (ANLL) are described. The chief presenting feature at relapse was painless testicular enlargement, as is also seen in ch

Continuous infusion mitoxantrone in rela
Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia
✍ Lynne S. Kaminer; Kyung E. Choi; Karen M. Daley; Richard A. Larson 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 2 views

Mitoxantrone is a substituted anthraquinone with considerable activity against human acute leukemia. The authors' goal was to treat patients with continuous infusion mitoxantrone in order to maintain cytotoxic steady state levels with acceptable toxicity and to assess the results. Daily mitoxantrone